The ROE as of March 2026 (TTM) for Oruka Therapeutics, Inc. (ORKA) is -25.30%

According to Oruka Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -25.30%. This represents a change of 298.44% compared to the average of -6.35% of the last 4 quarters.

Oruka Therapeutics, Inc. (ORKA) Historical ROE (quarterly & annually)

How has ORKA ROE performed in the past?

The mean historical ROE of Oruka Therapeutics, Inc. over the last ten years is -59.89%. The current -25.30% ROE has changed -57.76% with respect to the historical average. Over the past ten years (40 quarters), ORKA's ROE was at its highest in in the December 2022 quarter at -2.82%. The ROE was at its lowest in in the June 2024 quarter at -68.29%.

Oruka Therapeutics, Inc. (ORKA) ROE by Quarter and Year

Discovering the peaks and valleys of Oruka Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oruka Therapeutics, Inc. (ORKA) Average ROE

How has ORKA ROE performed in the past?

The current ROE of Oruka Therapeutics, Inc. (ORKA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oruka Therapeutics, Inc. (ORKA) ROE vs. Peers

How is ORKA’s ROE compared to its peers?

Oruka Therapeutics, Inc.’s ROE is less than Phathom Pharmaceuticals, Inc. (55.14%), greater than BridgeBio Oncology Therapeutics Inc. (-65.52%), greater than Rapport Therapeutics, Inc. Common Stock (-28.85%), greater than Kodiak Sciences Inc. (-246.19%), greater than Xencor, Inc. (-14.58%), greater than Nurix Therapeutics, Inc. (-57.51%), less than AnaptysBio, Inc. (1.81%), less than UroGen Pharma Ltd. (170.21%), greater than Oculis Holding AG (-62.46%), greater than Mind Medicine (MindMed) Inc. (-84.39%),

Build a custom stock screener for Oruka Therapeutics, Inc. (ORKA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oruka Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oruka Therapeutics, Inc. (ORKA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oruka Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.